Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000659

Drug Information
SynonymsNCGC00163492-02; (2R,3S,E,E)-2,3-Epoxy-4-oxo-7,10-dodecadienamide; Bio2_000478; (2R,3S)-3-nona-4,7-dienoyloxirane-2-carboxamide; C12058; KBioSS_000616; LS-63388; KBio3_001091; 3-nona-4,7-dienoyloxirane-2-carboxamide; cerulenin; Helicocerin; AC1L1FI4; AC1L6R79; 2,3-Epoxy-4-oxo-7,10-dodecadienoylamide; C2389_SIGMA; NCI60_000363; 7,10-DODECADIENAMIDE, 2,3-EPOXY-4-OXO-; KBio2_000616; (2R-(2alpha,3alpha(4E,7E)))-3-(1-Oxonona-4,7-dienyl)oxirane-2-carboxamide; KBio2_003184; 17397-89-6; KBio2_005752; NSC116069; CID28517; (2S)(3R)-2,3-Epoxy-4-oxo-7,10-dodecadienoylamide; NCGC00163492-01; AC1NQZF4; HMS1990P17; CID5352018; Bio2_000958; AC1Q5H5H; (2S,3R)-2,3-epoxy-4-oxy-7,10-dodecadienoylamide; Cerulenin, Cephalosporium caerulens; (2R,3S)-2,3-Epoxy-4-oxo-7E,10E-dodecadienamide; CID5282054; SMP1_000098; 2,3-Epoxy-4-oxo-7,10-dodecadienamide; BRD-K52075040-001-02-2; (2r,3s)-3-(nona-4,7-dienoyl)oxirane-2-carboxamide; QTL1_000017; 3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide; Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-; Oxiranecarboxamide, 3-[(4E,7E)-1-Oxo-4,7-nonadienyl]-, (2R,3S)-; DB01034; AC1NS1LT; NSC 116069; CHEMBL45627; Ambotz17397-89-6; CID272023; CHEBI:171741; KBioGR_000616; IDI1_002233; Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2-alpha,3-alpha(4E,7E)))-; (2R,3S)-3-((4E,7E)-nona-4,7-dienoyl)oxirane-2-carboxamide; MolPort-003-928-099; KBio3_001092; CPD-6901; (2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide; HMS1362P17; EINECS 241-424-8; BSPBio_001276; (2R,3S)-3-((4E,7E)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide; HMS1792P17; 3-(1-Oxo-4,7-nonadienyl)oxiranecarboxamide; Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2-alpha,3-alpha(4E,7E)))- (9CI)    
IndicationDramatic weight lossApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnti-Infective Agents    
CAS NumberCAS 17397-89-6
PubChem Compound IDCID 5352018.    
PubChem Substance IDSID 8139660.    
TargetFatty acid synthaseInhibitor[2][3][4]
Ref 1Novel agents in the management of Mycobacterium tuberculosis disease. Curr Med Chem. 2007;14(18):2000-8. To Reference
Ref 2Inhibition of Fatty Acid Biosynthesis Prevents Adipocyte Lipotoxicity on Human Osteoblasts In Vitro. J Cell Mol Med. 2009 Mar 27. [Epub ahead of print] To Reference
Ref 3Proliferation inhibition and apoptosis induction of K562 cells by fatty acid synthase inhibitor--cerulenin. Zhonghua Xue Ye Xue Za Zhi. 2000 May;21(5):244-6. To Reference
Ref 4The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol Rev. 1976 Sep;40(3):681-97. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543